STOCK TITAN

[Form 4] Acadia Healthcare Company, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Acadia Healthcare (ACHC) reported an insider equity award for its Chief Financial Officer, Todd S. Young. On 10/27/2025, he acquired 48,445 shares of common stock at $0.00 per share. According to the filing, these shares will vest over three years in equal annual installments beginning 10/27/2026. Following this transaction, Young beneficially owned 48,445 shares, held directly.

Acadia Healthcare (ACHC) ha comunicato un premio azionario interno per il suo Chief Financial Officer, Todd S. Young. Il 27/10/2025 ha acquistato 48.445 azioni ordinarie al prezzo di $0,00 per azione. Secondo la documentazione, queste azioni matureranno nel corso di tre anni in rate annuali uguali, a partire dal 27/10/2026. Dopo questa operazione, Young possedeva beneficiamente 48.445 azioni, detenute direttamente.

Acadia Healthcare (ACHC) informó sobre una asignación de acciones para su Director Financiero, Todd S. Young. El 27/10/2025 compró 48.445 acciones ordinarias a un precio de $0,00 por acción. Según el archivo, estas acciones se consolidarán durante tres años en cuotas anuales iguales, a partir del 27/10/2026. Tras esta operación, Young poseía beneficiosamente 48.445 acciones, mantenidas directamente.

Acadia Healthcare (ACHC)는 최고재무책임자(CFO)인 Todd S. Young를 위한 내부자 주식 보상을 보고했습니다. 2025년 10월 27일에 그는 주당 $0.00에 보통주 48,445주를 취득했습니다. 신고서에 따르면 이 주식은 3년 동안 매년 동일한 분할로 vest되며 시작은 2026년 10월 27일에 이루어집니다. 이 거래 이후 Young는 직접 보유하여 48,445주를 사실상 소유하게 됩니다.

Acadia Healthcare (ACHC) a annoncé une attribution d’actions internes pour son directeur financier, Todd S. Young. Le 27/10/2025, il a acquis 48 445 actions ordinaires au prix de $0,00 par action. Selon le dépôt, ces actions seront acquises sur une période de trois ans, par des versements annuels égaux, à partir du 27/10/2026. À la suite de cette transaction, Young possédait bénéficiairement 48 445 actions, détenues directement.

Acadia Healthcare (ACHC) meldete eine Insider-Eigenkapitalzuwendung für seinen Chief Financial Officer, Todd S. Young. Am 27.10.2025 kaufte er 48.445 Aktien Stammaktien zum Preis von $0,00 pro Aktie. Laut dem Filing werden diese Aktien über drei Jahre hinweg in gleichen jährlichen Raten vesten, beginnend am 27.10.2026. Nach dieser Transaktion besaß Young wirtschaftlich gesehen 48.445 Aktien, direkt gehalten.

Acadia Healthcare (ACHC) أبلغت عن منحة أسهم داخلية لمديرها المالي التنفيذي، Todd S. Young. في 27/10/2025، اشترى 48,445 سهماً من الأسهم العادية بسعر $0.00 للسهم. وفقاً للملف، ستستحق هذه الأسهم على مدى ثلاث سنوات بنسخ سنوية متساوية بدءاً من 27/10/2026. بعد هذه الصفقة، أصبح Young يمتلك بشكل فعّال 48,445 سهماً، مملوكة مباشرةً.

Positive
  • None.
Negative
  • None.

Acadia Healthcare (ACHC) ha comunicato un premio azionario interno per il suo Chief Financial Officer, Todd S. Young. Il 27/10/2025 ha acquistato 48.445 azioni ordinarie al prezzo di $0,00 per azione. Secondo la documentazione, queste azioni matureranno nel corso di tre anni in rate annuali uguali, a partire dal 27/10/2026. Dopo questa operazione, Young possedeva beneficiamente 48.445 azioni, detenute direttamente.

Acadia Healthcare (ACHC) informó sobre una asignación de acciones para su Director Financiero, Todd S. Young. El 27/10/2025 compró 48.445 acciones ordinarias a un precio de $0,00 por acción. Según el archivo, estas acciones se consolidarán durante tres años en cuotas anuales iguales, a partir del 27/10/2026. Tras esta operación, Young poseía beneficiosamente 48.445 acciones, mantenidas directamente.

Acadia Healthcare (ACHC)는 최고재무책임자(CFO)인 Todd S. Young를 위한 내부자 주식 보상을 보고했습니다. 2025년 10월 27일에 그는 주당 $0.00에 보통주 48,445주를 취득했습니다. 신고서에 따르면 이 주식은 3년 동안 매년 동일한 분할로 vest되며 시작은 2026년 10월 27일에 이루어집니다. 이 거래 이후 Young는 직접 보유하여 48,445주를 사실상 소유하게 됩니다.

Acadia Healthcare (ACHC) a annoncé une attribution d’actions internes pour son directeur financier, Todd S. Young. Le 27/10/2025, il a acquis 48 445 actions ordinaires au prix de $0,00 par action. Selon le dépôt, ces actions seront acquises sur une période de trois ans, par des versements annuels égaux, à partir du 27/10/2026. À la suite de cette transaction, Young possédait bénéficiairement 48 445 actions, détenues directement.

Acadia Healthcare (ACHC) meldete eine Insider-Eigenkapitalzuwendung für seinen Chief Financial Officer, Todd S. Young. Am 27.10.2025 kaufte er 48.445 Aktien Stammaktien zum Preis von $0,00 pro Aktie. Laut dem Filing werden diese Aktien über drei Jahre hinweg in gleichen jährlichen Raten vesten, beginnend am 27.10.2026. Nach dieser Transaktion besaß Young wirtschaftlich gesehen 48.445 Aktien, direkt gehalten.

Acadia Healthcare (ACHC) أبلغت عن منحة أسهم داخلية لمديرها المالي التنفيذي، Todd S. Young. في 27/10/2025، اشترى 48,445 سهماً من الأسهم العادية بسعر $0.00 للسهم. وفقاً للملف، ستستحق هذه الأسهم على مدى ثلاث سنوات بنسخ سنوية متساوية بدءاً من 27/10/2026. بعد هذه الصفقة، أصبح Young يمتلك بشكل فعّال 48,445 سهماً، مملوكة مباشرةً.

Acadia Healthcare (ACHC) 报告了首席财务官的内部股权奖励,Todd S. Young。在2025/10/27,他以每股$0.00购买了48,445股普通股。根据备案,这些股票将于三年内以等额年度分期的方式解锁,自2026/10/27起开始。交易后,Young以直接持有的方式受益所有权为48,445股

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
YOUNG TODD S.

(Last) (First) (Middle)
6100 TOWER CIRCLE, SUITE 1000

(Street)
FRANKLIN TN 37067

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Acadia Healthcare Company, Inc. [ ACHC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
10/27/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/27/2025 A 48,445(1) A $0.00 48,445 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Shares will vest over a 3-year period in equal yearly installments beginning October 27, 2026.
/s/ Brian Farley as Attorney in Fact for Todd S. Young 10/28/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did ACHC disclose on Form 4?

The CFO, Todd S. Young, acquired 48,445 shares of common stock at $0.00 on 10/27/2025.

What is the vesting schedule for the ACHC CFO’s shares?

The shares will vest in equal yearly installments over 3 years beginning 10/27/2026.

How many ACHC shares does the CFO own after the transaction?

Following the transaction, the CFO beneficially owned 48,445 shares.

What is the ownership form of the ACHC CFO’s holdings?

The filing lists the ownership form as Direct (D).

Who signed the ACHC Form 4 and when?

It was signed by /s/ Brian Farley as Attorney-in-Fact for Todd S. Young on 10/28/2025.
Acadia Healthcar

NASDAQ:ACHC

ACHC Rankings

ACHC Latest News

ACHC Latest SEC Filings

ACHC Stock Data

2.14B
90.62M
1.78%
116.36%
12.82%
Medical Care Facilities
Services-specialty Outpatient Facilities, Nec
Link
United States
FRANKLIN